Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) represents one of the leading causes of death worldwide. Published clinical trials suggest that the Chinese patent herbal medicine Shufeng Jiedu capsule (SFJD) is safe and may be effective for treating acute exacerbations of COPD (AECOPD). H...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ruyu, Fei, Yutong, Zhang, Lishan, Jie, Zhijun, Fan, Xiaoyun, Dai, Mengyuan, Moore, Michael, Willcox, Merlin, Hu, Xiaoyang, Francis, Nick, Liang, Changhao, Fei, Guanghe, Liu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546128/
https://www.ncbi.nlm.nih.gov/pubmed/37775286
http://dx.doi.org/10.1136/bmjopen-2022-070864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546128/
https://www.ncbi.nlm.nih.gov/pubmed/37775286
http://dx.doi.org/10.1136/bmjopen-2022-070864

Ejemplares similares